Maximus, Inc. (NYSE:MMS – Get Free Report) announced a quarterly dividend on Monday, October 6th, RTT News reports. Stockholders of record on Friday, November 14th will be given a dividend of 0.30 per share by the health services provider on Monday, December 1st. This represents a c) dividend on an annualized basis and a dividend yield of 1.3%.
Maximus has a payout ratio of 18.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 20.8%.
Maximus Price Performance
Maximus stock opened at $91.25 on Monday. Maximus has a 12 month low of $63.77 and a 12 month high of $93.73. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $5.14 billion, a price-to-earnings ratio of 16.80 and a beta of 0.57. The stock’s 50 day moving average is $85.06 and its 200-day moving average is $75.44.
Insider Activity
In related news, insider Michelle F. Link sold 1,610 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider owned 13,508 shares in the company, valued at $1,227,336.88. This trade represents a 10.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Maximus
Institutional investors have recently made changes to their positions in the stock. AQR Capital Management LLC raised its holdings in Maximus by 177.2% during the 1st quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock worth $79,341,000 after purchasing an additional 750,031 shares during the last quarter. Norges Bank acquired a new position in shares of Maximus during the second quarter worth approximately $47,886,000. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Maximus by 40.0% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock valued at $117,921,000 after buying an additional 494,372 shares in the last quarter. Boston Partners lifted its position in Maximus by 113.6% in the 2nd quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock valued at $46,435,000 after acquiring an additional 349,529 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Maximus by 20.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider’s stock worth $115,620,000 after buying an additional 288,990 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
- Five stocks we like better than Maximus
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Streaming Shakeout: Which Stocks Could Rebound in Q4?
- What is a Dividend King?
- Get the Best Bang for Your Buck: 3 Low-Cost, High-Return ETFs
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Cybersecurity Stocks Poised for Long-Term Growth
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.